PIMA541684

TFF2 Monoclonal Antibody (1-2#), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA541684-Each-of-1 In Stock ₹ 43,387.50

PIMA541684 - Each of 1

₹ 43,387.50

In Stock

Quantity

1

Base Price: ₹ 43,387.50

GST (18%): ₹ 7,809.75

Total Price: ₹ 51,197.25

Antigen

TFF2

Classification

Monoclonal

Concentration

0.96 mg/mL

Formulation

PBS with 50% glycerol and 0.05% ProClin 300

Gene Accession No.

Q09030

Gene Symbols

Tff2

Immunogen

Recombinant protein Trefoil Factor 2. The antigen corresponds to amino acid range 27-129 of the target protein.

Quantity

200 μL

Primary or Secondary

Primary

Target Species

Rat

Product Type

Antibody

Isotype

IgG1 κ

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Clone

1-2#

Conjugate

Unconjugated

Gene

Tff2

Gene Alias

mSP; pancreatic spasmolytic polypeptide; PSP; SML1; SP; spasmolysin; Spasmolytic polypeptide; spasmolytic protein 1; Tff2; Trefoil factor 2; trefoil factor 2 (spasmolytic protein 1)

Host Species

Mouse

Purification Method

Protein A/G

Regulatory Status

RUO

Gene ID (Entrez)

116592

Content And Storage

-20°C

Form

Liquid

Related Products

Img

Thermo Scientific

PIPA5115954

--

Img

Thermo Scientific

PIMA525308

--

Img

Thermo Scientific

PIPA5120989

--

Img

Thermo Scientific

PIMA534951

--

Img

Thermo Scientific

PIPA5106495

--

Img

Thermo Scientific

PIMA534760

--

Img

Thermo Scientific

PIPA5111039

--

Img

Thermo Scientific

PIPA5115937

--

Description

  • Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing and protection of the gastrointestinal epithelia
  • These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain
  • SP (spasmolytic polypeptide), also designated Trefoil factor 2 (TFF2) precursor, is a trefoil protein that functions to inhibit gastrointestinal motility and gastric acid secretion
  • SP may also act as a structural component of the gastric mucus, possibly by stabilizing glycoproteins in the mucus gel through interactions with carbohydrate side chains
  • A downregulation of SP expression is associated with primary gastric cancer, and a progressive loss of this protein is likely to be involved in the early stage of the multi-step gastric carcinogenesis pathway.